Literature DB >> 15262562

Can the low HIV prevalence in Hong Kong be maintained?

Michael Kam-tim Chan1, Shui-shan Lee.   

Abstract

Hong Kong is an area with low HIV prevalence. Public health services provided through the methadone clinics and public sexually transmitted diseases clinics have contributed to the control of HIV in Hong Kong. Nevertheless, surveillance indicates that HIV infections are increasing, especially in young male Chinese. The seropositivity rate of HIV in injection drug users is also increasing. A significant number of sexually transmitted infections, including syphilis and gonorrhoea, continue to occur. Continuing vigilance is required to prevent an increase in HIV infections.

Entities:  

Mesh:

Year:  2004        PMID: 15262562     DOI: 10.1521/aeap.16.3.5.18.35533

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  5 in total

1.  Assessing the spatial distribution of methadone clinic clients and their access to treatment.

Authors:  Ngai Sze Wong; Shui Shan Lee; Hui Lin
Journal:  Harm Reduct J       Date:  2010-07-05

Review 2.  Changing patterns of HIV epidemic in 30 years in East Asia.

Authors:  S Pilar Suguimoto; Teeranee Techasrivichien; Patou Masika Musumari; Christina El-saaidi; Bhekumusa Wellington Lukhele; Masako Ono-Kihara; Masahiro Kihara
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

3.  Achieving a high coverage--the challenge of controlling HIV spread in heroin users.

Authors:  Ming-qiang Li; Shui-shan Lee; Zhi-gao Gan; Yi Tan; Jin-Huai Meng; Ming-liang He
Journal:  Harm Reduct J       Date:  2007-02-15

4.  Community-Based Surveys for Determining the Prevalence of HIV, Chlamydia, and Gonorrhoea in Men Having Sex with Men in Hong Kong.

Authors:  H T H Wong; K H Wong; S S Lee; R W M Leung; K C K Lee
Journal:  J Sex Transm Dis       Date:  2013-04-09

5.  Examining the relationship between ethnicity and the use of drug-related services: an ethnographic study of Nepali drug users in Hong Kong.

Authors:  Wai-Man Tang
Journal:  Subst Abuse Rehabil       Date:  2014-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.